Please use a PC Browser to access Register-Tadawul
Get It
Evotec Receives $5M Milestone Payment From Bristol Myers Squibb Following FDA IND Acceptance Under Strategic Protein Degradation Partnership
Bristol-Myers Squibb Company BMY | 59.10 | -1.47% |
Evotec SE EVO | 2.43 | -2.80% |
